➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Moodys
Medtronic
McKesson
Dow

Last Updated: June 12, 2021

DrugPatentWatch Database Preview

LAMIVUDINE Drug Profile


Email this page to a colleague

« Back to Dashboard

Which patents cover Lamivudine, and when can generic versions of Lamivudine launch?

Lamivudine is a drug marketed by Aurobindo Pharma Ltd, Lannett Co Inc, Annora, Apotex, Arise, Cipla, Hetero Labs Ltd V, Lupin Ltd, Macleods Pharms Ltd, Mylan, Mylan Labs Ltd, Pharma Life, Strides Pharma, Anda Repository, Hetero Labs Ltd Iii, Pharmacare, Teva Pharms, and Micro Labs. and is included in thirty-three NDAs.

The generic ingredient in LAMIVUDINE is lamivudine; nevirapine; zidovudine. There are twenty-nine drug master file entries for this compound. Additional details are available on the lamivudine; nevirapine; zidovudine profile page.

Drug patent expirations by year for LAMIVUDINE
Drug Prices for LAMIVUDINE

See drug prices for LAMIVUDINE

Recent Clinical Trials for LAMIVUDINE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Fundação Bahiana de InfectologiaPhase 3
Fundacion SEIMC-GESIDAPhase 2
Federal University of BahiaPhase 4

See all LAMIVUDINE clinical trials

Medical Subject Heading (MeSH) Categories for LAMIVUDINE

US Patents and Regulatory Information for LAMIVUDINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacare LAMIVUDINE AND ZIDOVUDINE lamivudine; zidovudine TABLET;ORAL 022018-001 Mar 17, 2017 DISCN No No   Get Started Free   Get Started Free   Get Started Free
Aurobindo Pharma Ltd LAMIVUDINE AND ZIDOVUDINE lamivudine; zidovudine TABLET;ORAL 077558-001 May 5, 2017 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Strides Pharma LAMIVUDINE lamivudine TABLET;ORAL 090457-001 Apr 19, 2018 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Aurobindo Pharma Ltd LAMIVUDINE AND ZIDOVUDINE lamivudine; zidovudine TABLET;ORAL 202418-001 May 15, 2012 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Strides Pharma LAMIVUDINE lamivudine TABLET;ORAL 090457-002 Apr 19, 2018 AB RX No No   Get Started Free   Get Started Free   Get Started Free
Aurobindo Pharma Ltd LAMIVUDINE lamivudine SOLUTION;ORAL 077695-001 Nov 21, 2016 AA RX No No   Get Started Free   Get Started Free   Get Started Free
Lupin Ltd LAMIVUDINE lamivudine TABLET;ORAL 205217-001 Dec 18, 2014 AB RX No No   Get Started Free   Get Started Free   Get Started Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Johnson and Johnson
Express Scripts
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.